semaglutide type 1 diabetes automated insulin delivery randomized trial 2025 Use With in Adults With Diabetes: Qualitative Analyses and Patient-reported Outcomes From a Controlled ADA 2025 Recap: Improving Lives

In recent years, within the last ten years, several therapeutic drug managements (TDM) have been developed to manage DDIs (162)

4 reported observational data from Shanghai Sixth Peoples Hospital, China, showing that, with adequate treatment duration, GLP-1 agonists may have disease-modifying effects in patients with KOA with comorbid Type 2 diabetes, potentially mediated by weight loss

Squamous cell carcinoma is the most common type of cancer in the HNC region

High-resolution C1s spectra further revealed that the proportion of C-C/C = C of A-CDs and AA-CDs is 74.2% and 62.7%, respectively, agreement with above result (Fig